Britannia Life Sciences Inc

Recent News

  • Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders

    Toronto, Ontario--(Newsfile Corp. - December 16, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to announce the results of its annual meeting of shareholders (the "Meeting") held on December 15, 2022. A total of 70,547,689 common shares of the Company were represented at the Meeting, representing approximately 43.48% of the total number of common shares of the Company issued and outstanding.All matters presented for approval at the Meeting were duly authorized and...

    2022-12-16 8:30 AM EST
  • Britannia Life Sciences Inc. Reports Second Quarter Financial Results

    Toronto, Ontario--(Newsfile Corp. - November 29, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to provide its unaudited financial results for the three- and six-month periods ended September 30, 2022. These filings and additional information regarding Britannia are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars unless otherwise stated.Q2 2023 Highlights:Q2 revenue for the three- and six-month periods ended September 30, 2022 was $1.59m and $3.10m.During the...

    2022-11-29 8:30 AM EST
  • Britannia Life Sciences Inc. Reports First Quarter Financial Results

    Toronto, Ontario--(Newsfile Corp. - August 30, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to provide its unaudited financial results for the three months ended June 30, 2022. These filings and additional information regarding Britannia are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars unless otherwise stated.Q1 2023 Highlights:The Company reports Adjusted EBITDA of $626k for the three-month period ended June 30, 2022. For the three-month period ended...

    2022-08-30 9:28 AM EDT
  • Britannia Mining Solutions Inc. Signs Agreements to Deploy 10 Additional Chrysos PhotonAssay(TM) Units

    Britannia Mining Solutions will install and operate a total of 12 Chrysos PhotonAssay™ units in strategically important mining centres globally using an innovative hub-and-spoke modelPositions Britannia as a leader in offering technology-enabled, data rich and ESG friendly assay solutions to the global mining industryFirst PhotonAssay™ unit to be deployed in Q3 2023 in Montreal, serving as an initial regional hub for eastern CanadaToronto, Ontario--(Newsfile Corp. - August 11, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia") is pleased...

    2022-08-11 8:30 AM EDT
  • Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results

    Toronto, Ontario--(Newsfile Corp. - August 2, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to provide its financial results for the three- and twelve-month periods ended March 31, 2022. These filings and additional information regarding Britannia are available for review on SEDAR at www.sedar.com.Fiscal 2022 Financial Highlights (all amounts are Canadian dollars unless otherwise stated)[1]:The Company reports revenue and Adjusted EBITDA of $7.3m and $3.7m respectively for the twelve-month period ended March 31,...

    2022-08-02 8:30 AM EDT
  • Britannia Life Sciences to Mobilize Chrysos PhotonAssay(TM) Units in Mining Solutions Division

    Britannia Mining Solutions, will install and operate two Chrysos PhotonAssay™ units with the first unit to be delivered in H2 2023Chrysos PhotonAssay™ delivers faster, safer and more accurate gold analysis, and is an environmentally friendly replacement for fire assayEstablishes Britannia as the global mining industry's leading technology-enabled and ESG friendly solutionToronto, Ontario--(Newsfile Corp. - May 16, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia") is pleased to announce that its partially owned subsidiary, Britannia Mining Solutions...

    2022-05-16 9:28 AM EDT
  • Britannia Life Sciences Announces Closing of £5,000,000 Loan Facility

    Proceeds to be used to repay Sellers' Note and acquire an additional 10% of ADSLFive-year term provides Company with significant financial flexibility5 year term, 9.5% interest rate, no equity kickersToronto, Ontario--(Newsfile Corp. - April 7, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia") is pleased to announce the closing of a £5,000,000 loan facility (the "Loan Facility").The proceeds of the Loan Facility will be used to repay, in full, the remaining amounts due to the vendors of...

    2022-04-07 4:05 PM EDT
  • Britannia Life Sciences Establishes New Subsidiary to Service the Global Mining Sector

    Britannia Mining Solutions Inc. ("BMS") will deliver assay services to global mining companiesBMS is being funded separately from Britannia Life Sciences and is backed by a distinguished group of mining investors and advisors including Eric Sprott and Dr. Quinton HenninghBMS' focus will be establishing technology-enabled assay labs which will provide faster and more accurate results, and help address the global backlog of mining assaysToronto, Ontario--(Newsfile Corp. - March 8, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia")...

    2022-03-08 4:30 PM EST